Postprandial glycemia

There are 7 papers on postprandial glycemia in aging research: 5 trials in people, 2 reviews.

Biomarker

7 papers study it18 more mention it5 findings

3 new papers in 30 daysSee all 25 papers on postprandial glycemia

  • Human trial5

Interventions

3

Acarbose

downin humans3

3 studies
  1. Acarbose decreases postprandial glycemia in humans (230 +/- 24 vs. 148 +/- 20 mg/dl; p < 0.01).

    “postprandial glycaemia (230 +/- 24 vs. 148 +/- 20 mg/dl; p < 0.01)”

    Human trialin patients with well-compensated cirrhosis and type 2 diabetes treated with insulin, versus placebo28 weeks

    Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis

    Diabetes, obesity & metabolism

  2. Acarbose decreases postprandial glycemia in humans (type 2 diabetes mellitus with secondary sulfamide resistance).

    “High confidence level decrease in postprandial glycemia was recorded as was significant reduction in diurnal glucosuria.”

    Human trialtype 2 diabetes mellitus with secondary sulfamide resistancen = 63

    The use of the alpha-glucosidase inhibitor acarbose for the treatment of type-2 diabetes mellitus in secondary sulfanilamide resistance

    Likars'ka sprava

  3. Acarbose decreases postprandial glycemia in humans (non-insulin-dependent diabetic patients) (p = 0.0001).

    “since it significantly reduces the amount of postprandial glycemia and HbA1”

    Human trialnon-insulin-dependent diabetic patients3 x 50 mg/day, then 3 x 100 mg/daythree months per phasen = 90

    Clinical efficacy and tolerance to acarbose in the treatment of non-insulin-dependent diabetic patients

    Medicina clinica

More on Acarbose

D-allulose

downin humans1

1 study
  1. D-allulose decreases postprandial glycemia in humans.

    “controlled human studies support modest attenuation of postprandial glycemia and, in some settings, insulin responses.”

    Review

    D-Allulose as a Candidate Modulator of Nutrient-Responsive Signaling: The Metabo Quit Hypothesis for Healthy Aging

    Frontiers in endocrinology

More on D-allulose

Standing

no changein humans1

1 study
  1. Standing showed no clear effect on postprandial glycemia in humans after breakfast (β = -4.5 mg/dl/2 hr, 95% CI [-17.3, 8.4]).

    “A generalized linear model revealed no significant differences for the incremental area under the curve of glucose between standing for 10 min, 30 min after breakfast, versus prolonged sitting after breakfast”

    Human trialafter breakfast10 min2 hr

    Does Interrupting Prolonged Sitting With 10- or 20-Min Standing Attenuate Postprandial Glycemia and Blood Pressure in Middle-Aged and Older Adults With Type 2 Diabetes?

    Journal of aging and physical activity

More on Standing

Latest

Dec 2025: 0Jan 2026: 2Feb 2026: 2Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 29 papers in 12 months

See all 25 papers on postprandial glycemia